Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence.
about
Is cognitive functioning impaired in methamphetamine users? A critical reviewKhat use and neurobehavioral functions: suggestions for future studiesEEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further researchNeuropsychological Consequences of Chronic Drug Use: Relevance to Treatment ApproachesAn Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future ResearchAddiction and the brain-disease fallacyAn evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans.Distributed attentional deficits in chronic methamphetamine abusers: evidence from the Attentional Network Task (ANT)Neuropsychological Dysfunction among HIV Infected Drug AbusersMethamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration.Distinct roles of methamphetamine in modulating spatial memory consolidation, retrieval, reconsolidation and the accompanying changes of ERK and CREB activation in hippocampus and prefrontal cortexPharmacologic Treatment with GABA(B) Receptor Agonist of Methamphetamine-Induced Cognitive Impairment in Mice.Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice.Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuseOntogeny of the adrenal response to (+)-methamphetamine in neonatal rats: the effect of prior drug exposure.Functional and structural brain changes associated with methamphetamine abuseMethamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults.Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinenceMetabolic Abnormalities in Abstinent Methamphetamine Dependent SubjectsLonger term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence.Inhibition of sigma-1 receptor reduces N-methyl-D-aspartate induced neuronal injury in methamphetamine-exposed and -naive hippocampi.Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings.Effects of exposure to amphetamine derivatives on passive avoidance performance and the central levels of monoamines and their metabolites in mice: correlations between behavior and neurochemistry.Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: a pilot field studyCognitive functions in methamphetamine induced psychosis compared to schizophrenia and normal subjects.Effect of methamphetamine dependence on inhibitory deficits in a novel human open-field paradigmThe need for speed: an update on methamphetamine addiction.Impairment of adult hippocampal neural progenitor proliferation by methamphetamine: role for nitrotyrosination.Gestation time-dependent pharmacokinetics of intravenous (+)-methamphetamine in rats.Neurocognitive impact of substance use in HIV infection.Methamphetamine-induced changes in the object recognition memory circuit.Overlapping cognitive patterns in schizophrenia and methamphetamine dependence.Visual memory in methamphetamine-dependent individuals: deficient strategic control of encoding and retrieval.Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals.Evidence for subtle verbal fluency deficits in occasional stimulant users: quick to play loose with verbal rules.Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype?Potentiation of N-methyl-D-aspartate receptor-mediated neuronal injury during methamphetamine withdrawal in vitro requires co-activation of IP3 receptors.Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits.More alike than different: health needs, services utilization, and outcomes of Asian American and Pacific Islander (AAPI) populations treated for substance use disordersPerseverative behavior in rats with methamphetamine-induced neurotoxicity.
P2860
Q24606455-366FE4F3-8BF1-4708-8063-94F42F32E4B8Q24610235-C22C492C-878D-4221-8026-CDB2A22C611DQ24657705-01E15E52-BFD3-4F5F-A932-7696CB2BE4E1Q26772775-02C1E12E-3087-46C8-97B0-DE573BF09413Q26829172-074D86A1-EFF5-4269-A03F-5B31FFBF4B2FQ26865252-DA60D49B-525E-4DD7-A312-A3079E4B278DQ26866314-3FDF1D11-D144-46EA-948E-F9024E6D5635Q30381226-29A60F35-1F51-4919-AF41-AFB86782B773Q30389107-5988D83C-B9FE-4066-8990-C804FEBC74F0Q30443801-CE0273EE-4EB6-4D16-9F5F-105EFB3F86D6Q30455928-5D4DE93C-06B1-4E75-979C-E547FB9DCCB7Q30474281-EBB0D372-7040-48F0-BB2D-35079392A6F0Q30475706-3B91F268-2E1C-4EA6-B07B-987657F93DE7Q30484807-274CF2B4-B5E4-4C31-9DC7-ECEC63B510A3Q30486220-C2FAA2F3-128A-406A-8A8F-E5D4C01C807FQ30833169-C3A50857-0DEC-482B-B779-D9BA11AC3F8BQ33624189-813A986F-5318-4029-8A20-74EEB0F2A601Q33810923-38DFD4D3-CA84-4A4D-8FB8-BBD774481C18Q33858507-503E5BA6-5214-4983-AB2A-E30B55C591F6Q34026010-0577322C-5F07-46BD-95EC-717D50DBDE39Q34072874-7DE957DC-AF92-4FCE-87FA-E7D9E23838B1Q34132390-37186CB9-232F-470B-B1B5-C12A7A0AC69DQ34223687-70A8A85C-CC22-4373-BC5B-1B73C27F9403Q34713806-60352F01-1D07-47E6-982B-4EBE7AC3E4E7Q34778452-DCFB149F-DBB0-4F86-86D4-AB8452C422CFQ35007722-523D405F-F71E-4523-86FE-BFAFE93C4B18Q35012661-160B466C-01FB-4846-8467-138167B214DCQ35123948-A2EB0DC8-8A05-4698-BB68-B5C4FACFDA92Q35187893-0A4011F3-BFD8-484D-B8CE-C2BF03C37A10Q35245735-1CC5A215-2497-4E55-AC56-5B3E1D2114FBQ35685517-3EDEF88C-7257-4E78-B78F-A53CCB88BEF1Q35720265-B5CD4201-0AC8-4BA5-B6D2-87DD1E36B375Q35755045-5FE0C287-011D-4D11-BE18-9BCBF8255117Q35954607-A82B5238-0EAB-4179-AF5A-D9EC852FC50BQ36179302-55C4F154-BC2D-43FC-A7A7-7E923F84B04DQ36241219-E8526DE0-1750-4332-A254-663A79D6454EQ36340654-D8B7C091-6395-44C5-B136-27F6E71B752BQ36363825-15839939-57DE-4CE5-9264-7B07F05E7DD3Q36479381-2316B472-2D54-4609-A409-B63FA996E510Q36582079-126D7C29-D6F1-4477-9DD8-53C0557E456A
P2860
Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Methamphetamine dependence is ...... initial phases of abstinence.
@en
Methamphetamine dependence is ...... initial phases of abstinence.
@nl
type
label
Methamphetamine dependence is ...... initial phases of abstinence.
@en
Methamphetamine dependence is ...... initial phases of abstinence.
@nl
prefLabel
Methamphetamine dependence is ...... initial phases of abstinence.
@en
Methamphetamine dependence is ...... initial phases of abstinence.
@nl
P356
P1476
Methamphetamine dependence is ...... initial phases of abstinence.
@en
P2093
Ari D Kalechstein
Thomas F Newton
P304
P356
10.1176/JNP.15.2.215
P577
2003-01-01T00:00:00Z